US Patent 10584174 Anti-Dkk-1-anti-RANKL bispecific antibody compounds
Patent 10584174 was granted and assigned to Eli Lilly and Company on March, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10584174 Anti-Dkk-1-anti-RANKL bispecific antibody compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.